{
  "name" : "dacemirror.sci-hub.se_journal-article_12e7bcdd91718aad8e5aaac18801b044_farhadi2019.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Nano-Porous Metal–Organic Framework as a Novel Catalyst for the Synthesis of Spiro[indene[1,2-d] pyrimidine-ones and Investigation of Their Antimicrobial Activities",
    "authors" : [ "Simin Farhadi", "Mohammad Ali Ghasemzadeh", "Seyyed Soheil Aghaei" ],
    "emails" : [ "NiCo2O4@Ni(BDC)", "NiCo2O4@Ni(BDC)" ],
    "sections" : [ {
      "heading" : null,
      "text" : "1 2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n33\n34\n35\n36\n37\n38\n39\n40\n41\n42\n43\n44\n45\n46\n47\n48\n49\n50\n51\n52\n53\n54\n55\n56\n57\nz Biological Chemistry & Chemical Biology\nNiCo2O4@Ni(BDC) Nano-Porous Metal–Organic Framework as a Novel Catalyst for the Synthesis of Spiro[indene[1,2-d] pyrimidine-ones and Investigation of Their Antimicrobial Activities Simin Farhadi,[a] Mohammad Ali Ghasemzadeh,*[a] and Seyyed Soheil Aghaei[b]\nIn this research, an efficient and simple method has been reported for the preparation of spiro[indene[1,2-d]pyrimidineone derivatives through the multi-component reactions of cyclic ketones, urea/thiourea/guanidine and 1,3-indandion in the presence of NiCo2O4@Ni(BDC) (terephthalic acid) nanocatalyst. In this method, the products were obtained in short reaction times and excellent yields. The prepared metal-organic frameworks have been fully analyzed by fourier transform infrared spectrophotometry (FT-IR), field emission scanning electron microscopy (FE-SEM), energy-dispersive X-ray spectroscopy (EDX), thermogravimetric analysis (TGA),vibrating sample magnetometry (VSM), transmission electron microscopy (TEM), N2 adsorption-desorption by Brunauer–Emmett-Teller (BET) and X-ray diffraction (XRD)analysis. In addition, all of the synthesized pyrimidines screened against different pathogenic bacteria including Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa and also their antifungal activity were investigated against Candida albicans."
    }, {
      "heading" : "Introduction",
      "text" : "Multicomponent reactions (MCRs) are a synthetic approach in which more than three reactants combine to produce a new product. The special aspect of MCRs is that the final products include some all parts of substrates bringing forth almost no by-products.[1,2] This makes MCRs a highly ideal and eco-friendly reaction system. Desire compounds can be found in one-pot with much less process. Thus, MCRs have been of great interest in various research environments, such as discovery of lead compounds in chemical chemistry or combinatorial chemistry. The growth of multiple multidimensional reactions to medical and industrial scaffolding is inevitable at the present time. In addition, the combination of established multicomponent reactions created with post-reaction changes opens the way to a wide range of different and complicated products.[3,4]\nBiological importance of heterocyclic compounds is due to their potential physical and chemical properties.[5] The synthesis of heterocyclic compounds has been considerable attention because of diverse applications.[6] Among these compounds, pyrimidine derivatives occupy an unique role in pharmaceutical chemistry.[7] Pyrimidine compounds play a significant role as bactericidal,[8] fungicidal,[9] analgesics,[10] anti-inflammatory[11] and antitumor agents.[12] As pyrimidine is a basic nucleus in\nDNA & RNA, it has been found to be associated with diverse biological activities.[13]\nSeveral methods have been reported for the synthesis of pyrimidine derivatives which include: the Biginelli type reactions,[14]three-component condensation of aromatic aldehydes, ethyl cyanoacetate and guanidine nitrate,[15] multicomponent reaction of aromatic aldehydes, dibenzoylmethane, guanidinium carbonate,[16] and three-component condensation of cyclic ketones, urea/thiourea/guanidine and 1,3-diones.[17]\nSome of the pyrimidine derivatives (Fig.1) have several valuable biological properties such as anti-parasite[18] (Figure 1a), anti-tumor[19] (Figure 1b), and anti-bacterial activities[20] (Figure 1c).\nResearchers have been always tried to describe efficient and useful methods for the synthesis of heterocyclic compounds in high yields and short reaction times. In recent years considerable attention has been paid to nanostructures because of their valuable characteristics.\nMetal-organic frameworks (MOFs) are new nano-porous materials which recently take into attention as novel nanoporous materials.[21–23] As a highly diverse class of crystalline\n[a] S. Farhadi, Dr. M. A. Ghasemzadeh Department of Chemistry, Qom Branch, Islamic Azad University, Qom, I. R. Iran E-mail: Ghasemzadeh@qom-iau.ac.ir [b] Dr. S. S. Aghaei Department of Microbiology, Qom Branch, Islamic Azad University, Qom, I. R. Iran\nSupporting information for this article is available on the WWW under https://doi.org/10.1002/slct.201803260\nFull PapersDOI: 10.1002/slct.201803260\n729ChemistrySelect 2019, 4, 729–736 © 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim\nWiley VCH Dienstag, 15.01.2019 1902 / 127483 [S. 729/736] 1\n1 2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n33\n34\n35\n36\n37\n38\n39\n40\n41\n42\n43\n44\n45\n46\n47\n48\n49\n50\n51\n52\n53\n54\n55\n56\n57\nporous materials, MOFs have attracted great interest and a remarkable amount of MOFs structures have been designed and synthesized for various energies and environment relative applications such as gas separation and storage, ion exchange and sensors. In additions MOFs have been also used in drug delivery, catalysis, luminescent and fluorescent applications and optoelectronics materials.[24–31]\nMOFs-assisted organic synthesis using organic–inorganic hybrid micro-channels has been utilized not only to accelerate a number of synthetic reactions but also they are green catalyst to increase reaction rate and yields. MOF-based structures demonstrate various advantages such as high surface area, adjustable pore size and the simplicity of processing, tunability and use of stable alternative materials. Recently,MOFs were used as solid catalysts in some organic reactions such as Friedel–Crafts acylation,[32] Knoevenagel condensation,[33] Paal– Knorr,[34] Biginelli,[35] and also in the synthesis of cyclic carbonates,[36] pyrroles,[37] 2-amino-6-(alkylthio)pyridine-3,5-dicarbonitriles[38] and dihydro-2-oxypyrrole.[39]\nHerein, in continuation of the progress of the synthetic approach for the preparation of various heterocyclic compounds with biological activities, we wish to report the synthesis pyrimidine derivatives using a metal-organic framework NiCo2O4@Ni(BDC) as a novel, efficient and green heterogeneous catalyst (Scheme 1).[40–45] Moreover, we successfully\nevaluated the antibacterial and antifungal activities of the synthesized pyrimidine derivatives via disk diffusion method."
    }, {
      "heading" : "Results and Discussion",
      "text" : "Initially, the NiCo2O4@Ni(BDC) metal-organic framework was synthesized and characterized by different spectroscopic techniques including FE-SEM, EDX, TEM, BET, XRD, FT-IR, VSM and TGA.\nThe chemical purity of NiCo2O4@Ni(BDC) sample as well as its stoichiometry was tested by EDX study. The results of the Figure 2 show that typical characteristic peaks of Ni, O, C and Co elements in the survey spectrum, verifying existence of them in the NiCo2O4@Ni(BDC).\nScanning electron microscopy (SEM) is a useful tool for determining the size distribution, particle shape and porosity. Figure 3 shows FE-SEM images of the as-synthesized NiCo2O4@Ni(BDC) sample. Scanning electron microscopy of NiCo2O4@Ni(BDC) is obtained to investigate the morphology and the particle size of this organic–inorganic hybrid material. The results revealed that the presence of well-formed crystals.\nIn Figure 4, the morphology and particle size of the NiCo2O4@Ni(BDC) were studied using transmission electron microscopy (TEM). The TEM images show that small particles of 30–50 nm which confirmed by the FE-SEM images.\nNitrogen adsorption/desorption isotherms are used to investigate the specific surface area and pore volume distribution of nanostructures by the Brunauer-Emmett–Teller (BET) method. BET surface area and total pore volume of NiCo2O4@Ni (BDC) nanocomposite were 1.38 m2/g and of 8.85 cm3/g, respectively (Figure 5). It can be concluded that decreasing BET surface area and total pore volume can be attributed to the incorporation of NiCo2O4 nanoparticles inside and on the surfaces of the Ni(BDC) metal-organic framework.\nThe XRD pattern of the NiCo2O4@Ni(BDC) nanocatlyst is shown in Figure 6. The positions and relative diffraction peaks at around 2θ=18.890, 31.200, 36.880, 38.40, 44.470, 55.40, 59.160, 65.120, and 76.90 for NiCo2O4@Ni(BDC) nanocrystalline confirm well with its structure.[46]\nThe composition of NiCo2O4@Ni(BDC)wasfurtherstudied by Fourier transform infrared (FT-IR) (Figure 7). As shown, the NiCo2O4@Ni(BDC) spectrum shows more adsorption bands in comparison with NiCo2O4 nanoparticles. The absorption bands at 548 and 428 cm 1 are related to Ni O and Co O in NiCo2O4 nanoparticles (Figure 7a). For the NiCo2O4@Ni(BDC) metal organic frameworks (Figure 7b), characteristics peaks at 1678 and 733 cm 1 are assigned to the COO groups and absorption bands at 1508, 1423 and 1282 cm 1are assigned to the C=C and =C H bands in the BDC ring, respectively, which clearly indicates the presence of Ni(BDC).[47] Moreover, the stretching vibrations of Ni O and Co O are appeared at 548 and 428 cm 1 in the NiCo2O4@Ni(BDC) which confirms that the structure of the catalyst are keep.\nScheme 1. One-pot synthesis of pyrimidine derivatives using NiCo2O4@Ni (BDC) as catalyst\n730ChemistrySelect 2019, 4, 729–736 © 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim\nWiley VCH Dienstag, 15.01.2019 1902 / 127483 [S. 730/736] 1\n1 2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n33\n34\n35\n36\n37\n38\n39\n40\n41\n42\n43\n44\n45\n46\n47\n48\n49\n50\n51\n52\n53\n54\n55\n56\n57\nThe Magnetic properties of NiCo2O4 and NiCo2O4@Ni(BDC) were studied using vibration sample magnetometry (VSM) at room temperature. The magnetic saturation (MS) values of the NiCo2O4 NPs and NiCo2O4@Ni(BDC) were 5 emug 1 and 2\nemug 1, respectively (Figure 8). The slightly lower MS value of NiCo2O4@Ni(BDC) mainly results from the introduction of Ni (BDC). The presence of suitable magnetic properties allows NiCo2O4@Ni(BDC) to be completely, efficiently and quickly separated from the reaction mixture by an external magnet.\nFigure 3. FE-SEM images of NiCo2O4@Ni(BDC)\nFigure 4. TEM images of NiCo2O4@Ni(BDC)\nFigure 5. BET isotherm of NiCo2O4@Ni(BDC)\n731ChemistrySelect 2019, 4, 729–736 © 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim\nWiley VCH Dienstag, 15.01.2019 1902 / 127483 [S. 731/736] 1\n1 2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n33\n34\n35\n36\n37\n38\n39\n40\n41\n42\n43\n44\n45\n46\n47\n48\n49\n50\n51\n52\n53\n54\n55\n56\n57\nFigure 9 shows the thermogravimetric analysis (TGA) curve of NiCo2O4@Ni(BDC) MOF. This nanocomposite exhibited two-\nstage weight loss in the TGA curve. The first weight loss of the NiCo2O4@Ni(BDC) occurred below 350 °C, indicating the removal of the occluded DMF or waterwhich coordinated to frameworks. Below 350 °C, NiCo2O4@Ni(BDC) MOF exhibited weight loss of 23%–25% (wt) %. After the first weight loss, the TGA curve for the NiCo2O4@Ni(BDC) reached a plateau at temperatures of 380 to 430 °C. This illustrates the stability of the framework of the NiCo2O4@Ni(BDC) structure at the temperature of guest desorption and framework decomposition. The onset temperature of the second weight loss corresponded to the decomposition of organic species in the framework. The onset decomposition temperature at 450 °C was for NiCo2O4@Ni(BDC) in the second stage.\nIn continuation of our research the NiCo2O4@Ni(BDC) was assessed for its catalytic activity in the three-component synthesis of pyrimidines. Firstly, the reaction of 5-Cl-isatin, 1,3- indandion and guanidine was selected as model study\n(Scheme 2). The reaction conditions were optimized on the basis of the catalyst, solvent and different temperatures.\nTo show the merit of the present work toward previous studies, we conducted the model study in the presence of different catalysts using ethanol as solvent under reflux conditions. When the reaction was performed in the absence of catalysts no product was formed. Among various heterogeneous nanocatalysts including MgO, NiCo2O4@Ni(BDC), ZnO, CuI and also homogeneous catalysts such as NaOH and KOH, the best results (98% yield within 120 min) were obtained using NiCo2O4@Ni(BDC) as catalyst (Table 1).\nThe reaction was investigated in presence of different concentrations of the catalyst. As shown in Table 2, the use of\n0.005 g of the NiCo2O4@Ni(BDC) was enough to afford excellent yield of the corresponding pyrimidine within short reaction time. Moreover, we carried out the reaction in the presence of 0.007 g and 0.01 g of the catalyst, which showed no significant increase in comparison to use 0.005 g of the catalyst.\nAlso, the synthesis of 2-amino-5’-chlorospiro[indeno[1,2-d] pyrimidine-4,3’-indoline]-2’,5(1H)-dione (4h) was investigated under solvent-free conditions and also in the presence of\nFigure 8. Magnetization curves of the NiCo2O4(a) and NiCo2O4@Ni(BDC) (b)\nFigure 9. TGA profile of the NiCo2O4@Ni(BDC)\nScheme 2. Model reaction for the preparation of 2-amino-5’-chlorospiro [indeno[1,2-d]pyrimidine-4,3’-indoline]-2’,5(1H)-dione (4h)\nTable 1. Synthesis of 2-amino-5’-chlorospiro[indeno[1,2-d]pyrimidine-4,3’indoline]-2’,5(1H)-dione (4h) using various catalysts\nNumber Catalyst Time (min) Yields (%)\n1 NiCo2O4@Ni(BDC) 120 98 2 MgO 240 70 3 KOH 180 60 4 ZnO 240 83 5 CuI 180 75 6 NaOH 180 45\n732ChemistrySelect 2019, 4, 729–736 © 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim\nWiley VCH Dienstag, 15.01.2019 1902 / 127483 [S. 732/736] 1\n1 2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n33\n34\n35\n36\n37\n38\n39\n40\n41\n42\n43\n44\n45\n46\n47\n48\n49\n50\n51\n52\n53\n54\n55\n56\n57\ndifferent solvents such as ethanol, acetonitrile, toluene and water at different temperatures. The summarized results of Figure 10 show that ethanol is the best solvents in comparison with other solvents under reflux conditions.\nIn order to evaluate the generality of this model reaction, we prepared a range of pyrimidine derivatives under the optimized reaction conditions. In all cases, various cyclic ketones were successfully reacted and gave the expected products in good to excellent yields. The results are shown in Table 3.\nA plausible reaction mechanism for this three-component reaction is proposed in Scheme 3. The experimental results\nwere examined together with those in the literature.[49,50] NiCo2O4 is a member of the spinel group which has the standard formula A(B)2O4. The A metal is Ni\n+2 and the B metal is Co+3; two different metal ions in two specific sites. This arrangement causes a transfer of electrons between the different irons in a structured path or vector. This electric vector generates a magnetic field. In addition Ni+2 and Co+3 have unoccupied d orbitals and cause to Lewis acid properties of NiCo2O4.\n[51] Moreover, Ni(BDC) behaves as bifunctional catalyst, Ni acts as a Lewis site and O acts as Lewis base, respectively.[52]\nIt is assumed that catalyst plays an important role as a Lewis acid in promoting reaction between cyclic ketones and guanidine by activation of carbonyl groups in cyclic ketones to produce intermediate (I). Afterward, dehydration is done and an enone intermediate (II) was generated. Further, activation of carbonyl carbon of 1,3-Indandion by catalyst and its addition to the intermediate (II) in a Michael-type reaction undergoes a nucleophilic addition and the intracellular retinalization to provide the third intermediate. Finally, the dehydration of intermediate (III) resulted the final product 4a."
    }, {
      "heading" : "Results of Antimicrobial Activities",
      "text" : "The results of antimicrobial activities of the synthesized pyrimidine derivatives via Agar disk diffusion method are shown in Table 4 and Figure 11 and Figure 12. Measurement\nresults of diameter of the inhibition zones around each of disk showed that the greatest effect of the pyrimidne (4 h) with 18 mm on Pseudomonas aeruginosa (ATCC-27853) and Staph-\nFigure 10. The synthesis of pyrimidine 4h using different solvents at various\ntemperatures\nScheme 3. Plausible mechanism for the formation of pyrimidine derivatives by NiCo2O4@Ni(BDC) as catalyst\n733ChemistrySelect 2019, 4, 729–736 © 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim\nWiley VCH Dienstag, 15.01.2019 1902 / 127483 [S. 733/736] 1\n1 2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n33\n34\n35\n36\n37\n38\n39\n40\n41\n42\n43\n44\n45\n46\n47\n48\n49\n50\n51\n52\n53\n54\n55\n56\n57\n734ChemistrySelect 2019, 4, 729–736 © 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim\nWiley VCH Dienstag, 15.01.2019 1902 / 127483 [S. 734/736] 1\n1 2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n33\n34\n35\n36\n37\n38\n39\n40\n41\n42\n43\n44\n45\n46\n47\n48\n49\n50\n51\n52\n53\n54\n55\n56\n57\nylococcus aureus (ATCC-25923). Furthermore we observed that compound (4d) showed the lowest effect on the Pseudomonas aeruginosa (ATCC-27853 with 10 mm of inhibition zone. The summarized results of Table 4 show that ciprofloxacin had the inhibitoriest effect on the Staphylococcusaureus (ATCC-25923) bacteria with 16 mm and was resistant in comparison with Escherichia coli (ATCC-25922), Pseudomonas aeruginosa (ATCC27853) and Candida albicans (ATCC-10231). The compounds 4 h, 4i and 4e showed the highest inhibitory effect because of the halogen and sulfur groups which cause to increases the antimicrobial activities in compared to the other compounds (Figure 11,12).[53–56]"
    }, {
      "heading" : "Conclusions",
      "text" : "In this study, we succeeded in the production of spiro[indene [1,2-d]pyrimidine-one derivatives through the multi-component reactions of cyclic ketones, urea/thiourea/guanidine and 1,3- dionein the presence of NiCo2O4@Ni(BDC) nanocatalyst. Also, the antimicrobial effects of these compounds were investigated on pathogenic strains including Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Candida albicans. As seen, some of these compounds had antibacterial activity on Staphylococcus aureus and Pseudomonas aeruginosa, which was done by disc diffusion method. As a result of the increasing in antibiotic resistance, it is hoped to use various pyrimidine derivatives in pharmaceutical and medical applications. In this research, we tried to synthesize nanoparticles with a new approach and use them as a catalyst for the preparation of pyrimidine compounds. The benefits of this research include high product yields, simple reaction conditions, catalytic recovery capabilities, inexpensive and non-toxic catalysts and easy product separation steps.\nSupporting Information Summary\nThe reagents and analysis, experimental procedures, 1H and 13CNMR data of new compounds, catalyst recovery section and\nantimicrobial activity determination procedure are available in supporting information."
    }, {
      "heading" : "Acknowledgements",
      "text" : "This work was supported by the Islamic Azad University, Qom Branch, Qom, I. R. Iran, followed by [grant number 2014-13929]."
    }, {
      "heading" : "Conflict of Interest",
      "text" : "The authors declare no conflict of interest.\nKeywords: Antimicrobial · MOF · MCRs · Nanocomposite · NiCo2O4@Ni(BDC) · Pyrimidine\n[1] A. Domling, I. Ugi, Angew. Chem. Int. Ed. 2000, 39, 3168–3210; Angew. Chem. 2000, 112, 3300–3344. [2] A. Domling, Chem. Rev. 2006,106, 17–89. [3] M. Haji, J. Org. Chem. 2016, 12, 1269–1301. [4] M. A. DÞaz, M. Iglesias, N. Snejko, E. G. Puebla, M. Ý. Monge, Chem. Eur. J.\n2016, 22, 6654–6665. [5] R. Kharb, M. Tyagi, A. K. Sharma, Der.Pharma. Chem. 2014, 6, 298–320. [6] M. S. Mohamed, S. M. Awad, A. I. Sayed, Molecules, 2010, 15, 1882–1890. [7] M. H. Bukhari, H. L. Siddiqui, M. Ahmad, T. Hussain, M. G. Moloney, Med.\nChem. Res. 2011, 21, 2885–2895. [8] G. N. Pershin, L. I. Sherbakova, T. N. Zykova, V. N. Sakolova, Farm-\nakol.Toxicol. 1972, 35, 466–471. [9] G. Metolcsy, World. Rev. Pest. Contr. 1971,10, 50–59.\n[10] G. L. Regnier, R. J. Canevar, J. C. Le Douarec, S. Halstop, J. Daussy, J. Med .Chem. 1972,15, 295–301. [11] C. A. Winter, E. A. Fisley, G. W. Nuss, Proc. Soc. Exp. Biol. Med. 1962, 111, 544–547. [12] A. F. Suguira, M. M. Schmid, F. G. Brown, Cancer. Chemother. Rep. 1973, 3, 231–238. [13] T. A. Naik, K. H. Chikhalia, E- J. Chem. 2007, 4, 60–66. [14] B. L. Nilsson, L. E. Overman, J. Org. Chem. 2006, 71, 7706–7714. [15] A. Bhatewara, S. R. Jetti, T. Kadre, P. Paliwal, Sh. Jain, Arch. Appl. Sci. Res.\n2012, 4, 1274–1278. [16] E. Akbas, A. Levent, S. Gümü, M. R. Sümer, I. Akyazi, Bull. Korean. Chem.\nSoc. 2010, 31, 3632–3638. [17] G. Meshram, P. Wagh, Sh. Deshpande, V. Amratlal, Lett. Org. Chem. 2013,\n10, 445–450. [18] X. Deng, A. Nagle, T. Wu, T. Sakata, K. Henson, Z. Chen, K. Kuhen, D.\nPlouffe, E. Winzeler, F. Adrian, T. Tuntland, J. Chang, S. Simerson, S. Howard, J. Ek, J. Isbell, D. C. Tully, A. K. Chatterjee, N. S. Gray, Bioorg.Med. Chem. Lett. 2010, 20, 4027–4031. [19] J. X. Yuan, X. Q. Cai, D. M. Chen, M. L. Hu, Chin. J. Chem. 2007, 25, 417– 421. [20] J. Cieplik, k. M. Stolarczy, J. Pluta, O. Gubrynowicz, I. Bryndal, T. Lis, M. Mikulewicz, Acta. Pol. Pharm. 2011, 68, 57–65. [21] H. K. Chae, D. Y. Siberio-Perez, J. Kim, Y. Go, M. Eddaoudi, A. J. Matzger, M. O’Keeffe, O. M. Yaghi, Nature, 2004, 427, 523–527. [22] D. J. Tranchemontagne, Z. Ni, M. O’Keeffe, O. M. Yaghi, Angew. Chem. Int. Ed. 2008, 47, 5136–5147; Angew. Chem. 2008, 120, 5214–5225. [23] I. Ahmed, S. H. Jhung, Chem. Eng. J. 2017, 310, 197–215. [24] M. Eddaoudi, J. Kim, N. Rosi, D. Vodak, J. Wachter, M. O’Keeffe, O. M.\nYaghi, Science, 2002, 295, 469–472. [25] B. Chen, S. Xiang, G. Qian, Acc. Chem. Res. 2010, 43, 1115–24. [26] Y. S. Bae, R. Q. Snurr, Angew. Chem. Int. Ed. 2011, 50, 11586–96; Angew.\nChem. 2011, 123, 11790–11801. [27] J. S. Seo, D. Whang, H. Lee, S. I. Jun, J. Oh, Y. J. Jeon, K. Kim, Nature,\n2000, 404, 982–986. [28] M. D. Allendorf, C. A. Bauer, R. K. Bhakta, R. J. Houk, Chem. Soc. Rev.\n2009, 38, 1330–1352. [29] A. Lajevardi, M. Hossaini Sadr, M. Tavakkoli Yaraki, A. Badiei, M. A.\nArmaghan, New.J. Chem. 2018, 42, 9690–9701. [30] Y. Cui, Y. Yue, G. Qian, B. Chen, Chem. Rev. 2012, 112, 1126–1162.\n735ChemistrySelect 2019, 4, 729–736 © 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim\nWiley VCH Dienstag, 15.01.2019 1902 / 127483 [S. 735/736] 1\n1 2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n33\n34\n35\n36\n37\n38\n39\n40\n41\n42\n43\n44\n45\n46\n47\n48\n49\n50\n51\n52\n53\n54\n55\n56\n57\n[31] G. Xu, F. Gang, T. Dong, Y. Fu, Z. Du, Chin. J. Org. Chem. 2016, 36, 1513– 1527. [32] L. T. L. Nguyen, K. K. A. Le, N. T. S. Phan, Chin. J. Catal. 2012, 33, 688–696. [33] Y. Ren, J. Lu, O. Jiang, X. Cheng, J. Chen, Chin. J. Catal. 2015, 36, 1949–\n1956. [34] N. T. S. Phan, T. T. Nguyen, Q. H. Luu, L. T. L. Nguyen, J. Mol. Catal. A:\nChem. 2012,363–364, 178–185. [35] P. Li, S. Regati, R. J. Butcher, H. D. Arman, Z. Chen, S. Xiang, B. Chen,\nC G. Zhao, Tetrahedron Lett. 2011, 52, 6220–6222. [36] X. Zhou, Y. Zhang, X. Yang, L. Zhao, G. Wang, J. Mol. Catal. A: Chem.\n2012,361–362, 12–16. [37] J. Tang, M. Yang, M. Yang, J. Wang, W. Dong, G. Wang , New J. Chem.\n2015, 39, 4919–4923. [38] M. Thimmaiah, P. Li, S. Regati, B. Chen, J. C G. Zhao, Tetrahedron Lett.\n2012, 53, 4870–4872. [39] R. Ghorbani-Vaghei, H. Azarifar, S. Daliran, A. R. Oveisi, RSC. Adv. 2016, 6,\n29182–29189. [40] M. A. Ghasemzadeh, J. Safaei-ghomi, H. Molaei, C. R. Chim. 2012, 15,\n969–974. [41] S. M. Hasan Nasrollahi, M. A. Ghasemzadeh, M. R. Zolfaghari, Acta. Chim.\nSlov. 2018, 65, 199–207. [42] M. A. Ghasemzadeh, M. H. Abdollahi-Basir, B. Mirhosseini-Eshkevari,\nGreen. Chem. Lett. Rev. 2018, 11, 47–53. [43] M. A. Ghasemzadeh, B. Mirhosseini-Eshkevari, M. H. Abdollahi-Basir,\nComb. Chem. High. T. Scr. 2016, 19, 592–601. [44] M. A. Ghasemzadeh, N. Ghasemi-Seresht, Res. Chem. Intermed. 2015, 41,\n8625–8636.\n[45] B. Mirhosseini-Eshkevari, M. A. Ghasemzadeh, J. Safaei-ghomi, Res. Chem. Intermed. 2015, 41, 7703–7714. [46] S. Chaudhari, D. Bhattacharjya, J. S. Yu, Bull. Korean. Chem. Soc. 2015, 36, 2330–2336. [47] H. Y. Zhang, X. P. Hao, L. P. Mo, S. S. Liu, W. B. Zhang, Z. H. Zhang, New J. Chem. 2017, 41, 7108–7115. [48] G. Meshram, P. Wagh, S. Deshpande, V. Amratlal, Lett. Org. Chem. 2013, 10, 445–450. [49] C. O. Kappe, J. Org. Chem. 1997, 62, 7201–7204. [50] E. H. Hu, D. R. Sidler, U. H. Dolling, J. Org. Chem. 1998, 63, 3454–3457. [51] D. Chanda, J. Hnat, M. Paidar, K. Bouzek, Int. J. Hydrog. Energy. 2014, 39,\n5713–5722. [52] M. Aguirre-Díaz, L.; Gándara, F.; Iglesias, M.; Snejko, N.; Gutiérrez-Puebla,\nE.; Ángeles Monge, M. J. Am. Chem. Soc. 2015, 137, 6132–6135. [53] G. S. Waghmare, S. B. Junne, S. D. Shinde, A. S. Waghamare, S. V.\nKuberkar, Chem. Sci. Trans. 2013, 1, 1–4. [54] S. N. Darandale, D. N. Pansare, N. A. Mulla, D. B. Shinde, Bioorg. Med.\nChem. Lett. 2013, 9, 2632–2635. [55] V. Gressler, S. Moura, A. F. C. Flores, D. C. Flores, P. Colepicolob, E. Pintoa,\nJ. Braz. Chem. Soc. 2010, 21, 1477–1483. [56] A. Roquia, T. Ram, Int. J. Appl. Sci. Manag. 2016, 1, 105–116.\nSubmitted: October 18, 2018 Accepted: December 21, 2018\n736ChemistrySelect 2019, 4, 729–736 © 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim\nWiley VCH Dienstag, 15.01.2019 1902 / 127483 [S. 736/736] 1"
    } ],
    "references" : [ {
      "title" : "A",
      "author" : [ "M.S. Mohamed", "S.M. Awad" ],
      "venue" : "I. Sayed, Molecules",
      "citeRegEx" : "6",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "M",
      "author" : [ "H.K. Chae", "D.Y. Siberio-Perez", "J. Kim", "Y. Go", "M. Eddaoudi", "A.J. Matzger" ],
      "venue" : "O’Keeffe, O. M. Yaghi, Nature",
      "citeRegEx" : "21",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "M",
      "author" : [ "M. Eddaoudi", "J. Kim", "N. Rosi", "D. Vodak", "J. Wachter" ],
      "venue" : "O’Keeffe, O. M. Yaghi, Science",
      "citeRegEx" : "24",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "K",
      "author" : [ "J.S. Seo", "D. Whang", "H. Lee", "S.I. Jun", "J. Oh", "Y.J. Jeon" ],
      "venue" : "Kim, Nature",
      "citeRegEx" : "27",
      "shortCiteRegEx" : null,
      "year" : 2000
    }, {
      "title" : "Chem",
      "author" : [ "Y. Cui", "Y. Yue", "G. Qian", "B. Chen" ],
      "venue" : "Rev. 2012, 112, 1126–1162.  Table 4. Antimicrobial activity of synthesized compounds expressed as size of the inhibition zone (mm/mg sample) Compd  Species tested E. coli (ATCC- 25922)  S. aureus (ATCC- 25923)  P. aeruginosa (ATCC-27853)  C. albicans ",
      "citeRegEx" : "30",
      "shortCiteRegEx" : null,
      "year" : 1023
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "The synthesis of heterocyclic compounds has been considerable attention because of diverse applications.([6]) Among these compounds, pyrimidine derivatives occupy an unique role in pharmaceutical chemistry.",
      "startOffset" : 105,
      "endOffset" : 108
    } ],
    "year" : 2019,
    "abstractText" : "In this research, an efficient and simple method has been reported for the preparation of spiro[indene[1,2-d]pyrimidineone derivatives through the multi-component reactions of cyclic ketones, urea/thiourea/guanidine and 1,3-indandion in the presence of NiCo2O4@Ni(BDC) (terephthalic acid) nanocatalyst. In this method, the products were obtained in short reaction times and excellent yields. The prepared metal-organic frameworks have been fully analyzed by fourier transform infrared spectrophotometry (FT-IR), field emission scanning electron microscopy (FE-SEM), energy-dispersive X-ray spectroscopy (EDX), thermogravimetric analysis (TGA),vibrating sample magnetometry (VSM), transmission electron microscopy (TEM), N2 adsorption-desorption by Brunauer–Emmett-Teller (BET) and X-ray diffraction (XRD)analysis. In addition, all of the synthesized pyrimidines screened against different pathogenic bacteria including Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa and also their antifungal activity were investigated against Candida albicans.",
    "creator" : "ima-server®"
  }
}